Cargando…
PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells
Recent studies have indicated that therapeutic antibodies targeting PD-L1 show remarkable efficacy in clinical trials in multiple tumors and that a melanoma cell-intrinsic PD-1: PD-L1 axis promotes tumor growth. However, few studies have shown tumor-intrinsic PD-L1 effects in malignant melanoma init...
Autores principales: | Zheng, Fang, Dang, Jianzhong, Zha, Hui, Zhang, Bingyu, Lin, Ming, Cheng, Fanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700500/ https://www.ncbi.nlm.nih.gov/pubmed/29250533 http://dx.doi.org/10.1155/2017/1293201 |
Ejemplares similares
-
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
por: Santini, R, et al.
Publicado: (2014) -
Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-β1 in epithelial-to-mesenchymal transition in melanoma
por: Li, Zhen, et al.
Publicado: (2022) -
Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation
por: Tao, Zhennan, et al.
Publicado: (2018) -
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
por: López-Valero, Israel, et al.
Publicado: (2020) -
BRD4 regulates self‐renewal ability and tumorigenicity of glioma‐initiating cells by enrichment in the Notch1 promoter region
por: Tao, Zhennan, et al.
Publicado: (2020)